Major study of 59 million Americans finds fine particulate matter from air pollution increases heart disease risks

SINTBILO is approved in China to treat adult patients with primary hypercholesterolemia and mixed dyslipidemia. Credit: Naeblys / Shutterstock.com. Innovent Biologics has secured approval from

Healthcare should be a bigger focus than it likely will be at this week’s Republican National Convention, Rep. Rich McCormick, MD (R-Ga.), told MedPage Today